Patent details

Basic Information

Publication number:

EP3389640

PCT Application Number:

EP2016081367

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168229359

PCT Publication Number:

WO2017103057

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION COMPRISING ANHYDROUS DASATINIB

French Title of Invention:

COMPOSITION PHARMACEUTIQUE COMPRENANT DU DASATINIB ANHYDRE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT WASSERFREIEM DASATINIB

SPC Number:

Dates

Filing date:

16/12/2016

Grant date:

18/03/2020

EP Publication Date:

24/10/2018

PCT Publication Date:

22/06/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/03/2020

EP B1 Publication Date:

18/03/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/12/2020

Expiration date:

16/12/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/03/2020

 

 

Name:

Synthon B.V.

Address:

Microweg 22, 6545 CM Nijmegen, Netherlands (NL)

Inventor

1

Name:

ALVAREZ FERNANDEZ, Lisardo

Address:

Spain (ES)

2

Name:

GARCIA JIMENEZ, Sonia

Address:

Spain (ES)

3

Name:

VELADA CALZADA, Jose

Address:

Netherlands (NL)

Priority

Priority Number:

15200445

Priority Date:

16/12/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/20; A61K 9/28; A61K 31/506;

Publication

European Patent Bulletin

Issue number:

202012

Publication date:

18/03/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages